Transplantation Market Forecasts to 2028 - Global Analysis By Product (Preservation Solutions, Tissue Products, Immunosuppressive Drugs and Other Products), Application (Tissue Transplant, Organ Transplant and Other Applications), End User (Transplantation Centers, Hospitals and Other End Users) and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2022) |
US $13.81 BN |
|
Projected Year Value (2028) |
US $26.4 BN |
|
CAGR (2022 - 2028) |
11.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Transplantation Market is accounted for $13.8 billion in 2022 and is expected to reach $26.4 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Transplantation is a surgical procedure of implanting an organ or tissue from one body to another body. It is usually done when there is an organ failure. Organ failure generally occurs due to various factors such as serious trauma, loss of blood, poisoning, drug abuse, leukaemia, sepsis and other acute diseases. Transplantation was done to organs like heart, kidneys, liver, lungs, pancreas, intestine, thymus and uterus. Increase in chronic diseases such as kidney failure and lupus needs immediate change of organs which led to rise in transplantation.
According to the preliminary data from the Organ Procurement and Transplantation Network (OPTN), 42,000 organ transplants were performed in U.S with an increase of 5.9% and 1,22,915 patients are waiting to receive organs for transplant.
Market Dynamics:
Driver:
Increasing demand of 3D bioprinting
The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. The introduction of 3D bioprinting techniques has led to the growth of the transplantation market by driving the number of organ transplant procedures globally.
Restraint:
High cost for transplantation
Organ transplantation accumulates high cost due to its large process because every transplant organ must go through a series of evaluation, matching, screening and waiting procedures before it can be used in the transplant surgery. It is often difficult for patients to secure organs and transplant surgeries. The costs include the patient’s hospitalization as they stay before transplant also. Acquisition of organ donor for lesser prices is the most difficult aspect. This reason hampers the market growth.
Opportunity:
Advancement in transplantation technology
Advancement in transplantation technology and the launch of new products by manufacturers has raised the number of transplant procedures including kidney, liver, heart, lungs and tissues. This increased the number of transplant centers and healthcare centers. Well-developed healthcare infrastructure and availability of expert surgeons & advanced products with better technology has propelled the growth of the market.
Threat:
Extensive wait time
Organ transplantation takes extensive wait time due to the fewer organ donations. There is an increased need for these procedures to care for the critically patient population effectively. Even the donor is ready to donate the organ; the organ should match all the requisites and should be fully fledgeble to be transplanted. To get a perfect donor, it will almost take few months and can also be extended for too many years. This can sometimes even cause death of the patient and thus it hinders the growth of the market.
Covid-19 Impact
The covid pandemic did not hit the healthcare industry into disarray but caused a drop in organ transplant surgery enrolment worldwide. The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. The immunosuppressant drug interactions with COVID-19 therapy agents, had led to a significant number of organ failures from graft donors which became the major concern.
The tissue products segment is expected to be the largest during the forecast period
The tissue products segment is estimated to have a lucrative growth, due to its new product development. Major products used for tissue or organ transplantation are tissue products, immune suppressants and preservation solutions. It has raised the orthopedic procedures for tissue healing, normal functioning restoration and pain minimization. The increasing number of transplantation procedures such as that of cochlear, heart valves, bone marrow and orthopedic soft tissues and the rising geriatric population across the globe is attributed to the growth of the segment.
The immunosuppressive drugs segment is expected to have the highest CAGR during the forecast period
The immunosuppressive drugs segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the benefits this drug offers such as lowering the body ability to reject a transplanted organ. These drugs are highly used for auto immune disorders, such as alopecia areata, multiple sclerosis and arthritis, combined with the rising incidence of organ failures, especially the kidneys, lungs, liver, and heart.
Region with highest share:
North America is projected to hold the largest market share during the forecast period owing to their continuous development of innovative transplantation products for treatment. This region has well-developed healthcare system. The population here are increasing expenditure on personal health drastically. Strong presence of various large-scale biotechnology and medical device companies and presence of supportive government policies is expected to drive revenue growth of this region.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the increase in chronic diseases and road accidents. High prevalence of various chronic diseases and increasing incidence of road accidents are causing permanent damage to the organs resulting in replacement of damaged organs with healthy organs in order to save patient’s life. Continuous advancements in transplantation technology by major players in this region are registering the steady growth in the market.
Key players in the market
Some of the key players profiled in the Transplantation Market include Novartis AG, 21st Century Medicine, Stryker Corporation, TransMedics, Zimmer Biomet, Astellas Pharma Inc, Medtronic, AbbVie Inc, Biolife Solutions, Teva Pharmaceutical, Veloxis Pharmaceuticals Inc, Abbott, Becton, Dickinson and Company (BD), BioMérieux SA, Bio-Rad Laboratories Inc, CareDx Inc, F. Hoffmann-La Roche Ltd, Hologic Inc, Illumina Inc, QIAGEN and Arthrex Inc.
Key Developments:
In March 2022, Zimmer Biomet entered into a multiyear agreement with Bio composites to exclusively distribute Genex Bone Graft Substitute with its new mixing system and delivery options in the U.S.
In January 2022, Novartis AG collaborated with Alnylam intending to explore targeted therapy to restore liver function. Alnylam’s Sirna technology is intended to promote the regrowth of functional liver cells and is an alternative for liver failure patients.
Products Covered:
• Preservation Solutions
• Tissue Products
• Immunosuppressive Drugs
• Other Products
Applications Covered:
• Tissue Transplant
• Organ Transplant
• Other Applications
End Users Covered:
• Transplantation Centers
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Transplantation Market, By Product
5.1 Introduction
5.2 Preservation Solutions
5.3 Tissue Products
5.4 Immunosuppressive Drugs
5.5 Other Products
6 Global Transplantation Market, By Application
6.1 Introduction
6.2 Tissue Transplant
6.3 Organ Transplant
6.4 Other Applications
7 Global Transplantation Market, By End User
7.1 Introduction
7.2 Transplantation Centers
7.3 Hospitals
7.4 Other End Users
8 Global Transplantation Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Novartis AG
10.2 21 st Century Medicine
10.3 Stryker Corporation
10.4 TransMedics
10.5 Zimmer Biomet
10.6 Astellas Pharma Inc
10.7 Medtronic
10.8 AbbVie Inc
10.9 Biolife Solutions
10.10 Teva Pharmaceutical
10.11 Veloxis Pharmaceuticals Inc
10.12 Abbott
10.13 Becton, Dickinson and Company (BD)
10.14 BioMérieux SA
10.15 Bio-Rad Laboratories Inc
10.16 CareDx Inc
10.17 F. Hoffmann-La Roche Ltd
10.18 Hologic Inc
10.19 Illumina Inc
10.20 QIAGEN
10.21 Arthrex Inc
List of Tables
1 Global Transplantation Market Outlook, By Region (2020-2028) ($MN)
2 Global Transplantation Market Outlook, By Product (2020-2028) ($MN)
3 Global Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
4 Global Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
5 Global Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
6 Global Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
7 Global Transplantation Market Outlook, By Application (2020-2028) ($MN)
8 Global Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
9 Global Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
10 Global Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
11 Global Transplantation Market Outlook, By End User (2020-2028) ($MN)
12 Global Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
13 Global Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
14 Global Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
15 North America Transplantation Market Outlook, By Country (2020-2028) ($MN)
16 North America Transplantation Market Outlook, By Product (2020-2028) ($MN)
17 North America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
18 North America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
19 North America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
20 North America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
21 North America Transplantation Market Outlook, By Application (2020-2028) ($MN)
22 North America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
23 North America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
24 North America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
25 North America Transplantation Market Outlook, By End User (2020-2028) ($MN)
26 North America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
27 North America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
28 North America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
29 Europe Transplantation Market Outlook, By Country (2020-2028) ($MN)
30 Europe Transplantation Market Outlook, By Product (2020-2028) ($MN)
31 Europe Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
32 Europe Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
33 Europe Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
34 Europe Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
35 Europe Transplantation Market Outlook, By Application (2020-2028) ($MN)
36 Europe Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
37 Europe Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
38 Europe Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
39 Europe Transplantation Market Outlook, By End User (2020-2028) ($MN)
40 Europe Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
41 Europe Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
42 Europe Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
43 Asia Pacific Transplantation Market Outlook, By Country (2020-2028) ($MN)
44 Asia Pacific Transplantation Market Outlook, By Product (2020-2028) ($MN)
45 Asia Pacific Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
46 Asia Pacific Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
47 Asia Pacific Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
48 Asia Pacific Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
49 Asia Pacific Transplantation Market Outlook, By Application (2020-2028) ($MN)
50 Asia Pacific Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
51 Asia Pacific Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
52 Asia Pacific Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
53 Asia Pacific Transplantation Market Outlook, By End User (2020-2028) ($MN)
54 Asia Pacific Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
55 Asia Pacific Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
56 Asia Pacific Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
57 South America Transplantation Market Outlook, By Country (2020-2028) ($MN)
58 South America Transplantation Market Outlook, By Product (2020-2028) ($MN)
59 South America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
60 South America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
61 South America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
62 South America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
63 South America Transplantation Market Outlook, By Application (2020-2028) ($MN)
64 South America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
65 South America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
66 South America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
67 South America Transplantation Market Outlook, By End User (2020-2028) ($MN)
68 South America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
69 South America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
70 South America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
71 Middle East & Africa Transplantation Market Outlook, By Country (2020-2028) ($MN)
72 Middle East & Africa Transplantation Market Outlook, By Product (2020-2028) ($MN)
73 Middle East & Africa Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
74 Middle East & Africa Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
75 Middle East & Africa Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
76 Middle East & Africa Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
77 Middle East & Africa Transplantation Market Outlook, By Application (2020-2028) ($MN)
78 Middle East & Africa Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
79 Middle East & Africa Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
80 Middle East & Africa Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
81 Middle East & Africa Transplantation Market Outlook, By End User (2020-2028) ($MN)
82 Middle East & Africa Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
83 Middle East & Africa Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
84 Middle East & Africa Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.